CA.1aj.9

(redirected from G250)

CA.1aj.9

A gene on chromosome 9p12 that encodes a carbonic anhydrase, a zinc metalloenzyme that catalyses the reversible hydration of carbon dioxide. Carbonic anhydrases participate in various biological processes, including respiration, calcification, maintaining acid-base balance and bone resorption, as well as producing aqueous humour, cerebrospinal fluid, saliva and gastric acid. CA9 is a transmembrane protein and the only known tumour-associated carbonic anhydrase isoenzyme, and may be involved in cell proliferation and transformation.

Molecular pathology
CA9 is expressed in all clear-cell type renal cell carcinomas, but is not expressed in normal kidney or most other normal tissues.
Mentioned in ?
References in periodicals archive ?
The KPMG Currents of Change report is based on reviews of 4,500 companies in 45 countries in three categories: accounting for carbon emissions and related reporting, the quality of CR reporting in the G250 (250 largest companies in the Fortune Global 500, headquartered in 31 countries), and global trends in CR reporting in the G250 and N100 (100 largest companies in 45 countries).
After electrophoresis the gel was stained with Coomassie brilliant blue G250 and distained in solution containing methanol and acetic acid.
Bradford's reagent (Dissolved 50 mg of Coomassie-Brilliant blue G250 in 50 mL of methanol and added 100 mL of 85% phosphoric acid to the 1st solution.
Ninety-two percent of the G250 companies report on sustainability (KPMG Survey of Corporate Responsibility Reporting, 2015, http://bit.
By examining KPMG surveys from the years 2002, 2005, 2008, 2011, and 2013, we derived the following information: From 2002 to 2013, the percentage of G250 companies providing sustainability information to stakeholders grew from 45% to 93%, and the percentage of N100 companies providing sustainability information to stakeholders rose from 23% to 71% (see Figure 2).
Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: A phase I trial.
BSA concentrations were obtained from the Bradford method relying on the binding of the dye Coomassie Blue G250 to protein [32], The absorbance at 595 nm was determined by a UV-vis spectrophotometer (UV-1601, Shimadzu, Japan).
Muchos de los ocupantes eramos autodefensas, algunos habian participado en el G250.
El primer sobrenadante obtenido, se utilizo para la determinacion de proteina por el metodo de Bradford utilizando azul de Coomassie G250 a 595nm en un espectrofotometro UV-VIS GBC-911.
Protein content was determined by reacting the samples with a filtered solution on 40 Whatman paper containing 1% Coomassie Brilliant Blue G250 in ethanol, diluted 1:2 in 8.